Company intelligence / Profile preview

Eurofins Advinus

Bangalore/Bengaluru, Karnataka, Indiaadvinus.com ↗

Ownership: Private
Development stage: Other

Overview

Eurofins Advinus is not a product-based biotech but provides end-to-end drug discovery and development services. It has supported over 100 IND-enabling packages submitted to global regulators such as US FDA and EMA. The company has contributed to successful regulatory submissions for multiple clients across pharma/biotech/agrochemical sectors.

Therapeutic areas: ImmunologyMetabolic DisordersInfectious DiseasesNeurology
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Takeda Pharmaceutical Company Limited (multi-year drug discovery collaboration)Genzyme/Malaria Medicines Venture (malaria therapy collaboration)Merck & Co.Johnson & Johnson/JanssenNovartisCelgene Drugs for Neglected Diseases initiative/DNDi

Beyond the preview

Go deeper on Eurofins Advinus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurofins Advinus.

Explore the full profile